Iwona Pelikant-Małecka Selected Research

VU0357017

1/2019

Simultaneous activation of muscarinic and GABAB receptors as a bidirectional target for novel antipsychotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iwona Pelikant-Małecka Research Topics

Disease

1	Hypercholesterolemia 11/2023
1	Atherosclerosis 11/2023
1	Hypersensitivity (Allergy) 09/2023
1	Mast Cell Activation Disorders (Mast-Cell Disease) 09/2023
1	Anaphylaxis (Anaphylactic Shock) 09/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2023
1	Skin Diseases (Skin Disease) 05/2023
1	Neoplasms (Cancer) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Mastocytosis 11/2021
1	Cognitive Dysfunction 01/2020
1	Schizophrenia (Dementia Praecox) 01/2019
1	Neurobehavioral Manifestations 01/2019
1	Catalepsy 01/2019
1	Heart Valve Diseases (Valvular Heart Disease) 01/2014
1	Thrombosis (Thrombus) 01/2014
1	Inflammation (Inflammations) 01/2014

Drug/Important Bio-Agent (IBA)

2	NucleotidesIBA 11/2023 - 01/2014
1	Apolipoproteins E (ApoE)IBA 11/2023
1	Purine NucleotidesIBA 11/2023
1	EnzymesIBA 11/2023
1	Histones (Histone)IBA 09/2023
1	Tryptases (Tryptase)IBA 09/2023
1	Biomarkers (Surrogate Marker)IBA 05/2023
1	Proteins (Proteins, Gene)FDA Link 05/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2020
1	N,N'- dicyclopentyl- 2- methylsulfanyl- 5- nitro- pyrimidine- 4,6- diamineIBA 01/2019
1	3- amino- N- (4- methoxybenzyl)- 4,6- dimethylthieno(2,3- b)pyridine- 2- carboxamideIBA 01/2019
1	VU0357017IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Haloperidol (Haldol)FDA LinkGeneric 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	1- (4- methoxybenzyl)- 5- (trifluoromethoxy)indoline- 2,3- dioneIBA 01/2019

Therapy/Procedure

1	Immunotherapy 01/2022